学术探索
学术期刊
新闻热点
数据分析
智能评审

Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line

被引：213
作者：
Grothey, A [1 ]
Sargent, D [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 36期
关键词：
D O I：
10.1200/JCO.2005.04.4792
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9441 / 9442
页数：2
相关论文
共 13 条
  • [1] [Anonymous], 2002, P ASCO
  • [2] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    de Gramont, A
    Figer, A
    Seymour, M
    Homerin, M
    Hmissi, A
    Cassidy, J
    Boni, C
    Cortes-Funes, H
    Cervantes, A
    Freyer, G
    Papamichael, D
    Le Bail, N
    Louvet, C
    Hendler, D
    de Braud, F
    Wilson, C
    Morvan, F
    Bonetti, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2938 - 2947
  • [3] DEGRAMONT A, 2004, J CLIN ONCOL, V22, pS14
  • [4] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
    Douillard, JY
    Cunningham, D
    Roth, AD
    Navarro, M
    James, RD
    Karasek, P
    Jandik, P
    Iveson, T
    Carmichael, J
    Alakl, M
    Gruia, G
    Awad, L
    Rougier, P
    [J]. LANCET, 2000, 355 (9209) : 1041 - 1047
  • [5] A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    Goldberg, RM
    Sargent, DJ
    Morton, RF
    Fuchs, CS
    Ramanathan, RK
    Williamson, SK
    Findlay, BP
    Pitot, HC
    Alberts, SR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 23 - 30
  • [6] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
    Grothey, A
    Sargent, D
    Goldberg, RM
    Schmoll, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1209 - 1214
  • [7] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2335 - 2342
  • [8] Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer:: European Organisation for Research and Treatment of Cancer Gastrointestinal Group study 40986
    Köhne, CH
    van Cutsem, E
    Wils, J
    Bokemeyer, C
    El-Serafi, M
    Lutz, MP
    Lorenz, M
    Reichardt, P
    Rückle-Lanz, H
    Frickhofen, N
    Fuchs, R
    Mergenthaler, HG
    Langenbuch, T
    Vanhoefer, U
    Rougier, P
    Voigtmann, R
    Müller, L
    Genicot, B
    Anak, Ö
    Nordlinger, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 4856 - 4865
  • [9] Oratz R, 2005, J CLIN ONCOL, V23, p49S
  • [10] PITOT HC, 2005, J CLIN ONCOL, V23, pS16
12